Follow us on Twitter
twitter icon@FreshPatents


Infectious patents

      

This page is updated frequently with new Infectious-related patent applications.

SALE: 260+ Infectious-related patent PDFs



 Methods for detecting a biomarker by alternating current electrokinetics patent thumbnailnew patent Methods for detecting a biomarker by alternating current electrokinetics
Methods are described for detecting pathogens, infectious diseases, and physiological conditions by quantifying change of impedance over time of when a biological sample is applied onto a lab-on-a-chip. The lab-on-a-chip utilizes alternating-current electrokinetic (acek) phenomena such that molecules move or are carried in an electric field generated by the application of an electrical signal of predetermined magnitude and frequency to an electrode array of the lab-on-a-chip..
University Of Tennessee Research Foundation


 Nucleic acid amplification controls patent thumbnailnew patent Nucleic acid amplification controls
The present invention discloses positive control material for nucleic acid amplification based detection of microorganisms in biological samples. The control material comprises purified microorganism that is rendered non-infectious but is amenable to nucleic acid amplification.
Zeptometrix Corporation


 Double-stranded rna conjugates and their use patent thumbnailnew patent Double-stranded rna conjugates and their use
Double-stranded ribonucleic acids (dsrna) of at least 45 bp, preferably of at least 50 bp, which dsrna include at least one 5′-triphosphate group and further includes at least one chemical modification at a 5′ end, at a 3′ end and/or at a non-terminal nucleotide. The invention further provides pharmaceutical compositions containing such modified dsrnas, methods for their production, and to their use in medicine, in particular for immunostimulation and treatment as well as prevention of infectious, autoimmune, degenerative, cancer and tumor diseases..
Riboxx Gmbh


 Personal vaccine and  making patent thumbnailnew patent Personal vaccine and making
A method for the creation of a personalized vaccine. Multiple and varied antigens in conjunction with heat shock proteins (and other protein chaperones) are generated by ionized gas lysing coupled with the separation, concentration, and purification of these chaperone protein-antigen complexes (cpac) using insulator-dielectrophoresis (i-dep)-based devices.
Q21


 Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease patent thumbnailnew patent Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
The invention provides a chimeric receptor comprising nkg2d, dap10 and cd3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of nk cells.
National University Of Singapore


 Macrocyclic compounds as trk kinase inhibitors patent thumbnailnew patent Macrocyclic compounds as trk kinase inhibitors
Compounds of formula i: and pharmaceutically acceptable salts thereof, wherein ring a, ring b, w, m, d, r2, r2a r3 and r3a are as defined herein, are inhibitors of trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.. .
Array Biopharma, Inc.


 Compounds useful as immunomodulators patent thumbnailnew patent Compounds useful as immunomodulators
The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use.
Bristol-myers Squibb Company


 Personal vaccine and  making patent thumbnailnew patent Personal vaccine and making
A method for the creation of a personalized vaccine. Multiple and varied antigens in conjunction with heat shock proteins (and other protein chaperones) are generated by ionized gas lysing coupled with the separation, concentration, and purification of these chaperone protein-antigen complexes (cpac) using insulator-dielectrophorsis (i-dep)-based devices.
Q21


 Personal vaccine and  making patent thumbnailnew patent Personal vaccine and making
A method for the creation of a personalized vaccine. Multiple and varied antigens in conjunction with heat shock proteins (and other protein chaperones) are generated by ionized gas lysing coupled with the separation, concentration, and purification of these chaperone protein-antigen complexes (cpac) using insulator-dielectrophorsis (i-dep)-based devices.
Q21


 Personal vaccine and  making patent thumbnailnew patent Personal vaccine and making
A method for the creation of a personalized vaccine. Multiple and varied antigens in conjunction with heat shock proteins (and other protein chaperones) are generated by ionized gas lysing coupled with the separation, concentration, and purification of these chaperone protein-antigen complexes (cpac) using insulator-dielectrophorsis (i-dep)-based devices.
Q21


new patent

Assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease

An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. Also provided is an in vitro assay for determining the effect of an activated cd8+ t-cell on a sensitized melanoma cell.
The Trustees Of Columbia University In The City Of New York

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (hsp) preparation or an α-2-macroglobulin (α2m) preparation with a non-vaccine treatment modality. In particular, an hsp preparation or an α2m preparation is administered in conjunction with a non-vaccine treatment modality for the treatment of cancer or infectious diseases.
University Of Connecticut Health Center

Pharmaceutical compositions comprising danirixin for treating infectious diseases

Provided are compounds and pharmaceutically acceptable salts thereof, and combinations of compounds, their pharmaceutical compositions, their methods of preparation, and methods for their use in treating or preventing infectious disease.. .
Glaxosmithkline Intellectual Property (no. 2) Limited

Intraocular delivery devices and methods therefor

Injection devices for delivering pharmaceutical compositions into the eye are described. Some devices include a resistance component for controllably deploying an injection needle through the eye wall.
Ocuject, Llc

Ibv strains and uses thereof

The present invention relates to novel infectious bronchitis virus strains and the uses thereof. The invention particularly relates to an inactivated or attenuated ibv, as well as to vaccine compositions comprising the same and the uses thereof to vaccinate avians.
Biomune Company

Targeted conjugates and particles and formulations thereof

Nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker have been designed. Such nanoparticles and microparticles can provide improved temporospatial delivery of the active agent and/or improved biodistribution.
Tarveda Therapeutics, Inc.

Replication-competent vsv-hiv env vaccines

The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of aids. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention..
International Aids Vaccine Initiative

Vaccination with immuno-isolated cells producing an immunomodulator

Provided herein are vaccine compositions containing at least one retrievable biocompatible macrocapsule containing immuno-isolated allogeneic cells that secrete an immunomodulator such as gm-csf (granulocyte-macrophage colony stimulating factor) and an antigenic component such as autologous tumor cells or infectious agents. Also provided are kits and pharmaceutical compositions containing the vaccine compositions as well as methods of use thereof for therapeutic or preventative vaccination against tumors or infectious agents..
Maxivax Sa

Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders

The present invention relates to methods of treating infectious, inflammatory and post-traumatic disorders by administering various compounds newly discovered to have tlr4 inhibitory activity. In addition to methods of treatment, the present invention further provides for pharmaceutical compositions comprising said compounds, together with a suitable pharmaceutical carrier.
University Of Pittsburgh - Of The Commonwealth System Of Higher Education

Monoclonal antibodies to programmed death 1 (pd-1)

The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to pd-1 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided.
Ono Pharmaceutical Co., Ltd.

Inhibitors of lpxc

Provided herein, inter alia, are compounds and methods for treating infectious diseases. The compounds provided herein are, inter alia, useful for the treatment of bacterial infections.
The Regents Of The University Of California

Modular antigen transportation molecules and uses thereof in animals

The present invention relates to (isolated) recombinant proteins, also referred to as improved mat (imat) molecules, comprising at least one translocation module, at least one targeting module and at least one antigen module, wherein at least one cysteine residue is substituted with a different amino acid residue. Such imat molecules are useful specifically as vaccines, e.g.
Boehringer Ingelheim Vetmedica Gmbh

Cold-adapted-viral-attenuation (cava) and novel attenuated poliovirus strains

A poliovirus (pv) strain was attenuated by a novel method of cold-adapted-viral-attenuation (cava). The resulting recombinant attenuated pv, cava-pv, shows wild-type replication at 30° c., but no substantial replication at 37° c.
Crucell Holland B.v.

Vaccination with immuno-isolated cells producing an immunomodulator

Provided herein are vaccine compositions containing at least one retrievable biocompatible macrocapsule containing immuno-isolated allogeneic cells that secrete an immunomodulator such as gm-c sf (granulocyte-macrophage colony stimulating factor) and an antigenic component such as autologous tumor cells or infectious agents. Also provided are kits and pharmaceutical compositions containing the vaccine compositions as well as methods of use thereof for therapeutic or preventative vaccination against tumors or infectious agents..
Maxivax Sa

1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor

Provided is compound (i) or a pharmaceutically acceptable salt thereof, which is an inhibitor of trka kinase and is useful in the treatment of diseases which can be treated with a trka kinase inhibitor such as pain, cancer, inflammation and inflammatory diseases, neurodegenerative diseases, certain infectious diseases, sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis, pelvic pain syndrome, diseases related to an imbalance of the regulation of bone remodeling, and diseases resulting from connective tissue growth factor aberrant signaling.. .
Array Biopharma Inc.

Treatment of inflammatory and infectious skin disorders

Disclosed herein is a composition comprising of resveratrol and/or derivatives thereof and/or functionally related compounds and benzoyl peroxide and/or derivatives thereof and/or functionally related compounds for the treatment of acne and other inflammatory or infectious skin disorders. Also disclosed are methods of treating acne and other inflammatory and infectious skin disorders using the compositions described herein..
The Regents Of The University Of California



Infectious topics:
  • Infectious
  • Infectious Disease
  • Infectious Diseases
  • Autoimmune
  • Autoimmune Disease
  • Immune Disease
  • Modulation
  • Nucleotide
  • Killer Cells
  • Natural Killer Cell
  • Stem Cells
  • Amplification
  • Dna Sequence
  • Single Nucleotide Polymorphism
  • Nucleic Acid


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Infectious for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Infectious with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.137

    file did exist - 2657

    2 - 1 - 53